Literature DB >> 334500

[Prevention of postoperative thrombo-embolism by heparin/dihydroergotamine (author's transl].

K Koppenhagen, A Wiechmann, E Frey, H G Wenig, H Latka, H V Zühlke, E Tank, J Hardieck, H Ernst, R Häring.   

Abstract

Using the radiofibrinogen test and perfusion lung scanning (2-phase pharmacoscintigraphy), the incidence of postoperative thrombosis and pulmonary embolism was determined in a group of 362 operated patients. Low-dose heparin administration (twice 5000 IU daily) was given to 162, combined heparin and dihydroergotamine administration (5000 IU heparin and 0.5 mg dihydroergotamine daily) to 150, while 50 patients received no prophylactic treatment. There was a significant decrease in thrombo-embolism in the heparin/DHE group (8.7% deep-vein thrombosis; 2.7% pulmonary embolism) compared with the heparin group (19.8% and 5.5%, respectively) and the control group (30% and 14%, respectively).

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 334500     DOI: 10.1055/s-0028-1106729

Source DB:  PubMed          Journal:  Dtsch Med Wochenschr        ISSN: 0012-0472            Impact factor:   0.628


  4 in total

1.  [Perioperative prevention of thromboembolism in gynecology].

Authors:  W E Schreiner
Journal:  Arch Gynecol       Date:  1986

2.  Prevention of deep vein thrombosis in neurosurgical patients: a prospective double-blind comparison of two prophylactic regimen.

Authors:  D Voth; M Schwarz; K Hahn; K Dei-Anang; S al Butmeh; H Wolf
Journal:  Neurosurg Rev       Date:  1992       Impact factor: 3.042

3.  Dihydroergotamine and heparin or heparin alone for the prevention of postoperative thromboembolism in gynecology.

Authors:  M K Hohl; K P Lüscher; M Annaheim; R Fridrich; U F Gruber
Journal:  Arch Gynecol       Date:  1980

4.  [Thromboembolism prevention in surgical medicine: heparin or heparin-dihydroergotamine?].

Authors:  H Rasche; J Vollmar; C Burri; H G Beger; J Kilian; J Kinzl; W Krautzberger; C Wenzke
Journal:  Langenbecks Arch Chir       Date:  1983
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.